Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,183.46 +0.13%
EPS Growth %: +41.0%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: +41.0%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
(Updated - July 8, 2026 4:37 PM EDT)
Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- Eli Lilly: Q2 2026 acquired IPR&D charges estimated at $2.80B pre-tax.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Future Money Acquisition gets Nasdaq notice over late 10-Q filing
- Genco Shipping amends shareholder rights agreement, extends to 2027
Create E-mail Alert Related Categories
Guidance, Trader TalkRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
